Post Archive by Day

The Pan American Health Organization / World Health Organization (PAHO/WHO) recently confirmed Canada joined the United States, Israel, and the United Kingdom in detecting vaccine-derived poliovirus type 2 (VDPV2) in wastewater samples in 2022.
The Canadian National Microbiology Laboratory (NML) retrospectively tested wastewater samples and found 3 of 26 samples tested positive for poliovirus by real-time PCR.

The Pan American Health Organization / World Health Organization (PAHO/WHO) recently confirmed that Canada joined the United States, Israel, and the United Kingdom in detecting vaccine-derived poliovirus type 2 (VDPV2) in wastewater samples in 2022.
The Canadian National Microbiology Laboratory (NML) retrospectively tested wastewater samples and found 3 of 26 samples tested positive for poliovirus by real-time PCR.

The World Health Organization (WHO) African Region recently published some good and less than positive news regarding yellow fever.
On January 3, 2022, the WHO African Region published updated data that indicates the number of new yellow fever cases has steadily decreased.
From January 2021 to early December 2022, a total of 203 confirmed and 252 probable cases with 40 deaths (Case Fatality Ratio 9%) were reported, with a decline in new case reports throughout this period.

AstraZeneca today announced its Biologics License Application (BLA) for nirsevimab (Beyfortus®) had been accepted for review by the U.S. Food and Drug Administration (FDA) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease (LRTI) in newborns and infants entering or during their first RSV season.
And the BLA is for children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season.